CCM
TNDM icon

Catapult Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Catapult Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,710
Closed -$1.73M – 269
2013
Q4 		$1.73M Buy
+6,710
New +$1.54M 0.41% 70

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MACM
March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return

Catapult Capital Management's TNDM Position: Q1 2014 in Review

Catapult Capital Management sold out of Tandem Diabetes Care (TNDM) in Q1 2014, closing a stake of 6,710 shares — an estimated $1.73M sold.

Catapult Capital Management first reported a position in TNDM in Q4 2013 and held it in 1 quarter. The position peaked at $1.73M in Q4 2013. 65 funds tracked by Wall St. Rank hold TNDM as of Q1 2014.

  • Catapult Capital Management reported no remaining Tandem Diabetes Care position as of Q1 2014 after selling out during the quarter.
  • Catapult Capital Management sold 6,710 Tandem Diabetes Care shares in Q1 2014, an estimated $1.73M.
  • Catapult Capital Management first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 1 quarter.
  • Catapult Capital Management's Tandem Diabetes Care position peaked at $1.73M in Q4 2013.
  • 65 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2014.

Based on Catapult Capital Management's 13F filing for Q1 2014, filed 15 May 2014.